<p><b>TABLE OF INTERACTIONS WITH</b></p>

<p><b>OXCARBAZEPINE</b></p>

<p><b>See also: metabolized anticonvulsants</b></p>

<p><b>See also: hyponatremia inducing medications</b></p>

<p><b>See also: enzymatic inducers</b></p>

<p><b>From the French ANSM drug interactions document of September 2016, p. 170</b></p>

<table cellspacing="0" cellpadding="0" border="1">
<tbody>
<tr>
<td valign="top"><p><b>OXCARBAZEPINE</b></p>

<p><b>RxNorm: 32624</b></p>

<p><b>ATC: N03AF02</b></p></td>
<td valign="top"><p><b>NON-CONTRACEPTIVE ESTROGENS</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>G03C-001</b></p></td>
<td valign="top"><p>Risk of decrease of the effectiveness of the hormonal treatment, due to increase of its hepatic metabolism by the oxcarbazepine.</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring and possible adjustment of the dosage of the hormonal treatment during the treatment with the oxcarbazepine and after it is stopped<b>.</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>OXCARBAZEPINE</b></p>

<p><b>RxNorm: 32624</b></p>

<p><b>ATC: N03AF02</b></p></td>
<td valign="top"><p><b>LAMOTRIGINE</b></p>

<p><b>RxNorm: 28439</b></p>

<p><b>ATC: N03AX09</b></p></td>
<td valign="top"><p>Decrease of the concentrations of the lamotrigine with risk of lower effectiveness, due to increase of its hepatic metabolism by the oxcarbazepine</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring and testing of the plasma concentrations, with adjustment of the dosage of the lamotrigine if needed<b>.</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>OXCARBAZEPINE</b></p>

<p><b>RxNorm: 32624</b></p>

<p><b>ATC: N03AF02</b></p></td>
<td valign="top"><p><b>PERAMPANEL</b></p>

<p><b>RxNorm: 1356552</b></p>

<p><b>ATC: N03AX22</b></p></td>
<td valign="top"><p>Decrease by half of the concentrations of perampanel and slight increase of those of the oxcarbazepine.</p></td>
<td valign="top"><p><b>Take into account</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>OXCARBAZEPINE</b></p>

<p><b>RxNorm: 32624</b></p>

<p><b>ATC: N03AF02</b></p></td>
<td valign="top"><p><b>TOPIRAMATE</b></p>

<p><b>RxNorm: 38404</b></p>

<p><b>ATC: 38404</b></p></td>
<td valign="top"><p>Risk of decrease of the concentrations of the topiramate with risk of lower effectiveness, due to increase of its hepatic metabolism by the oxcarbazepine</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring and, if needed, adjustment of the dosage of the topiramate during the treatment with the oxcarbazepine and after it is stopped<b>. </b></p></td>
</tr>

</tbody>
</table>

